San Francisco Business Times -- Sunesis Pharmaceuticals Inc. registered with the Securities and Exchange Commission to raise up to $50 million selling stock and warrants. The South San Francisco business has just returned to the Nasdaq’s good graces — its stock, which closed at $1.15 a share on Monday afternoon, has traded above a dollar for more than 10 days now.
